ZEB1 expression is downregulated in AML patients, and acute deletion of Zeb1 in leukemic stem cells enhances disease progression in MLL-AF9 and Meis1a/Hoxa9 driven AML. This evidence concerns the gene KMT2A and acute myeloid leukemia.